Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$114.22 - $140.1 $17,704 - $21,715
-155 Reduced 4.32%
3,429 $475,000
Q4 2023

Feb 01, 2024

SELL
$75.49 - $124.16 $22,722 - $37,372
-301 Reduced 7.75%
3,584 $444,000
Q3 2023

Nov 17, 2023

SELL
$86.06 - $137.93 $98,624 - $158,067
-1,146 Reduced 22.78%
3,885 $362,000
Q2 2023

Jul 25, 2023

SELL
$112.47 - $130.98 $61,183 - $71,253
-544 Reduced 9.76%
5,031 $646,000
Q1 2023

Apr 19, 2023

SELL
$104.0 - $122.92 $45,864 - $54,207
-441 Reduced 7.33%
5,575 $647,000
Q4 2022

Feb 03, 2023

SELL
$84.98 - $122.67 $48,693 - $70,289
-573 Reduced 8.7%
6,016 $681,000
Q3 2022

Feb 17, 2023

BUY
$76.35 - $94.18 $43,748 - $53,965
573 Added 9.52%
6,589 $531,000
Q3 2022

Nov 08, 2022

SELL
$76.35 - $94.18 $203,625 - $251,178
-2,667 Reduced 28.81%
6,589 $531,000
Q2 2022

Jul 25, 2022

BUY
$67.99 - $132.89 $420,246 - $821,393
6,181 Added 201.01%
9,256 $690,000
Q1 2022

May 09, 2022

SELL
$94.08 - $130.2 $144,318 - $199,726
-1,534 Reduced 33.28%
3,075 $1.57 Million
Q4 2021

Jan 25, 2022

SELL
$129.87 - $162.82 $24,935 - $31,261
-192 Reduced 4.0%
4,609 $2.48 Million
Q3 2021

Oct 25, 2021

SELL
$106.71 - $143.18 $137,335 - $184,272
-1,287 Reduced 21.14%
4,801 $2.63 Million
Q2 2021

Jul 26, 2021

BUY
$80.99 - $107.93 $67,464 - $89,905
833 Added 15.85%
6,088 $2.6 Million
Q1 2021

Apr 21, 2021

SELL
$84.79 - $104.74 $48,839 - $60,330
-576 Reduced 9.88%
5,255 $1.89 Million
Q4 2020

Jan 19, 2021

BUY
$78.0 - $104.5 $12,480 - $16,720
160 Added 2.82%
5,831 $2.16 Million
Q3 2020

Oct 29, 2020

SELL
$95.51 - $112.95 $10,792 - $12,763
-113 Reduced 1.95%
5,671 $2.34 Million
Q2 2020

Jul 27, 2020

SELL
$62.68 - $105.34 $235,864 - $396,394
-3,763 Reduced 39.42%
5,784 $2.35 Million
Q1 2020

Apr 24, 2020

SELL
$47.79 - $75.63 $8,888 - $14,067
-186 Reduced 1.91%
9,547 $2.57 Million
Q4 2019

Jan 16, 2020

SELL
$36.62 - $57.29 $5,822 - $9,109
-159 Reduced 1.61%
9,733 $2.13 Million
Q3 2019

Oct 22, 2019

BUY
$35.53 - $43.8 $1,918 - $2,365
54 Added 0.55%
9,892 $1.48 Million
Q2 2019

Jul 15, 2019

BUY
$27.84 - $38.92 $3,006 - $4,203
108 Added 1.11%
9,838 $1.47 Million
Q1 2019

Apr 30, 2019

SELL
$28.07 - $38.18 $53,445 - $72,694
-1,904 Reduced 16.37%
9,730 $1.16 Million
Q4 2018

Jan 31, 2019

BUY
$26.99 - $37.37 $9,689 - $13,415
359 Added 3.18%
11,634 $1.39 Million
Q3 2018

Oct 26, 2018

SELL
$23.35 - $36.72 $84,643 - $133,110
-3,625 Reduced 24.33%
11,275 $1.61 Million
Q2 2018

Jul 26, 2018

BUY
$17.54 - $25.22 $261,346 - $375,778
14,900 New
14,900 $1.42 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.2B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Old National Bancorp Portfolio

Follow Old National Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

News

Stay updated on Old National Bancorp with notifications on news.